LENNOX-GASTAUT SYNDROME (LGS)
Clinical trials for LENNOX-GASTAUT SYNDROME (LGS) explained in plain language.
Never miss a new study
Get alerted when new LENNOX-GASTAUT SYNDROME (LGS) trials appear
Sign up with your email to follow new studies for LENNOX-GASTAUT SYNDROME (LGS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Seizure drug safety trial ends early for rare epilepsies
Disease control TerminatedThis study looked at the long-term safety of soticlestat when added to standard seizure medicines for people with Dravet syndrome or Lennox-Gastaut syndrome. It included children and adults who had already been in earlier studies. The trial was stopped early, but researchers were…
Matched conditions: LENNOX-GASTAUT SYNDROME (LGS)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
Epilepsy drug soticlestat safety trial ends early
Disease control TerminatedThis study looked at the long-term safety of soticlestat, an add-on seizure medicine, in children and adults with severe epilepsy syndromes like Dravet and Lennox-Gastaut. Participants took soticlestat twice daily and visited the clinic every 2-6 months. The study was terminated …
Matched conditions: LENNOX-GASTAUT SYNDROME (LGS)
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 10:34 UTC